- Home
- TYL vs BNTX Comparison
TYL vs BNTX Comparison
Compare TYL & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TYL | BNTX |
|---|---|---|
| Founded | 1966 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2B | 24.8B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | TYL | BNTX |
|---|---|---|
| Price | $467.48 | $92.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 11 |
| Target Price | ★ $652.82 | $137.40 |
| AVG Volume (30 Days) | 454.6K | ★ 1.5M |
| Earning Date | 10-29-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.32 | N/A |
| EPS | ★ 7.19 | N/A |
| Revenue | $2,298,292,000.00 | ★ $3,698,814,972.00 |
| Revenue This Year | $10.96 | $2.36 |
| Revenue Next Year | $8.90 | N/A |
| P/E Ratio | $63.67 | ★ N/A |
| Revenue Growth | ★ 10.62 | 3.70 |
| 52 Week Low | $445.64 | $81.20 |
| 52 Week High | $661.31 | $129.27 |
Technical Indicators
Market Signals| Indicator | TYL | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 53.90 | 36.99 |
| Support Level | $447.35 | $91.11 |
| Resistance Level | $462.80 | $93.32 |
| Average True Range (ATR) | 9.85 | 2.05 |
| MACD | 1.86 | -0.21 |
| Stochastic Oscillator | 86.87 | 19.53 |
Price Performance
Historical ComparisonAbout TYL Tyler Technologies Inc.
Tyler Technologies provides a full suite of software solutions and services that address the needs of cities, counties, schools, courts and other local government entities. The company's three core products are Munis, which is the core ERP system, Odyssey, which is the court management system, or CMS, and payments. The company also provides a variety of add-on modules and offers outsourced property tax assessment services.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.